UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acute Myeloid Leukemia

1st ed. 2021., 2021

Volltextzugriff (PDF)

Akute myeloische Leukämie: Therapie im Wandel

Deutsches Ärzteblatt Online, 2020-11

Röllig, Christoph

2020

Volltextzugriff (PDF)

Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib

Blood cancer journal (New York), 2022-05, Vol.12 (5), p.84-84, Article 84

2022

Volltextzugriff (PDF)

P556: A NEW MULTIPLEX PCR TOOL ENABLES TIMELY IDENTIFICATION OF ACTIONABLE TARGETS FOR MOLECULAR‐GUIDED THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e5284457-n/a

2023

Volltextzugriff (PDF)

Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL)

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2016, Vol.59 (4), p.444-453

2016

Volltextzugriff (PDF)

Neue Entwicklungen in der Therapie der akuten myeloischen Leukämie

Im Fokus Onkologie, 2016-11, Vol.19 (11), p.48-53

Röllig, Christoph

2016

Volltextzugriff (PDF)

Gegen CD38 gerichtete Therapie beim multiplen Myelom

InFo Hämatologie + Onkologie, 2019-12, Vol.22 (12), p.42-43

2019

Volltextzugriff (PDF)

S123: ACUTE MYELOID LEUKEMIA STEM CELL SUBTYPES DEFINED BY MUTATIONS AND DIFFERENTIATION STATE REGULATE APOPTOTIC DEPENDENCY AND CLINICAL RESPONSE TO VENETOCLAX

HemaSphere, 2023-08, Vol.7 (S3), p.e67012e0-n/a

2023

Volltextzugriff (PDF)

P528: CAN MULTIPARAMETRIC FLOW CYTOMETRY OF PERIPHERAL BLOOD CHALLENGE BONE MARROW ANALYSES FOR DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA?

HemaSphere, 2023-08, Vol.7 (S3), p.e263908f-n/a

2023

Volltextzugriff (PDF)

Prinzipien der AML-Therapie

InFo Hämatologie + Onkologie, 2019-08, Vol.22 (7-8), p.15-18

2019

Volltextzugriff (PDF)

PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH‐RISK MYELODYSPLASTIC SYNDROME: A FIRST‐IN‐CLINIC PHASE 1 STUDY OF GSK3745417

HemaSphere, 2023-08, Vol.7 (S3), p.e451088e-n/a

2023

Volltextzugriff (PDF)

PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE‐LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e06701e1-n/a

2023

Volltextzugriff (PDF)

FLT3-Inhibitoren in der Therapie der akuten myeloischen Leukämie

Best practice onkologie, 2018-06, Vol.13 (4), p.182-190

2018

Volltextzugriff (PDF)

Molecular Detection of Minimal Residual Disease Based on NPM1-Real-Time PCR At the Time of Complete Remission Is a Strong Predictor of Disease Free and Overall Survival in AML

Blood, 2011-11, Vol.118 (21), p.1445-1445

2011

Volltextzugriff (PDF)

Reconstitution of IL-17-Producing T Helper Cells After Allogeneic Hematopoietic Cell Transplantation

Blood, 2012-11, Vol.120 (21), p.4167-4167

2012

Volltextzugriff (PDF)

Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML – Interim Results of the Bridge Trial

Blood, 2012-11, Vol.120 (21), p.2017-2017

2012

Volltextzugriff (PDF)

Prevalence and Prognostic Impact of RUNX1 Mutations In Patients with Acute Myeloid Leukemia (AML): A Study In 1649 Patients Registered In the AML96 Protocol of the DSIL/SAL

Blood, 2010-11, Vol.116 (21), p.754-754

2010

Volltextzugriff (PDF)

High Plasma Lysyloxidase Concentration Is Associated with Inferior Outcome and Extramedullary Disease in Patients with Acute Myeloid Leukemia

Blood, 2011-11, Vol.118 (21), p.935-935

2011

Volltextzugriff (PDF)

Characterization of Extramedullary Acute Myeloid Leukemia – Results of the AML96 Trial

Blood, 2010-11, Vol.116 (21), p.2154-2154

2010

Volltextzugriff (PDF)

The HCT-Specific Comorbidity Index Fails to Predict Survival After Allogeneic HCT In High Risk AML Patients - A Single Center Experience

Blood, 2010-11, Vol.116 (21), p.1326-1326

2010

Volltextzugriff (PDF)

PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia

Blood, 2010-11, Vol.116 (21), p.2156-2156

2010

Volltextzugriff (PDF)

Sequential Combination of Azacitidine and Lenalidomide Can Target the TP53-Mutated Clone in Del(5q) Higher-Risk Myelodysplastic Syndromes

Blood, 2012-11, Vol.120 (21), p.921-921

2012

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Englisch
(196)
Deutsch
(16)

Erscheinungsjahr

n.n

Thema

Acute Myeloid Leukemia
(14)
Humans
(13)
Adult
(8)
Female
(8)
Middle Aged
(8)
Aged
(7)
Male
(7)
Leukemia
(6)
Medicine & Public Health
(6)
Treatment Outcome
(6)
Adolescent
(5)
Aml
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Leukemia, Myeloid, Acute - Drug Therapy
(5)
Medicine
(5)
Hematology
(4)
Hematology, Oncology And Palliative Medicine
(4)
Oncology
(4)
Prospective Studies
(4)
Young Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(118)
Journal Of Clinical Oncology
(11)
Hemasphere
(8)
Haematologica
(6)
Biology Of Blood And Marrow Transplantation
(4)
Info Onkologie
(4)
Clinical Lymphoma, Myeloma And Leukemia
(3)
Blood Advances
(2)
Der Internist
(2)
Info Hämatologie + Onkologie
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Acute Myeloid Leukemia

Akute myeloische Leukämie: Therapie im Wandel

Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib

P556: A NEW MULTIPLEX PCR TOOL ENABLES TIMELY IDENTIFICATION OF ACTIONABLE TARGETS FOR MOLECULAR‐GUIDED THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL)

Neue Entwicklungen in der Therapie der akuten myeloischen Leukämie

Gegen CD38 gerichtete Therapie beim multiplen Myelom

S123: ACUTE MYELOID LEUKEMIA STEM CELL SUBTYPES DEFINED BY MUTATIONS AND DIFFERENTIATION STATE REGULATE APOPTOTIC DEPENDENCY AND CLINICAL RESPONSE TO VENETOCLAX

P528: CAN MULTIPARAMETRIC FLOW CYTOMETRY OF PERIPHERAL BLOOD CHALLENGE BONE MARROW ANALYSES FOR DETECTION OF MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA?

Prinzipien der AML-Therapie

PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH‐RISK MYELODYSPLASTIC SYNDROME: A FIRST‐IN‐CLINIC PHASE 1 STUDY OF GSK3745417

PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE‐LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS

FLT3-Inhibitoren in der Therapie der akuten myeloischen Leukämie

Molecular Detection of Minimal Residual Disease Based on NPM1-Real-Time PCR At the Time of Complete Remission Is a Strong Predictor of Disease Free and Overall Survival in AML

Reconstitution of IL-17-Producing T Helper Cells After Allogeneic Hematopoietic Cell Transplantation

Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML – Interim Results of the Bridge Trial

Prevalence and Prognostic Impact of RUNX1 Mutations In Patients with Acute Myeloid Leukemia (AML): A Study In 1649 Patients Registered In the AML96 Protocol of the DSIL/SAL

Safety and Efficacy of a Combination of 5-Azacitidine Followed by Lenalidomide in High-Risk MDS or AML Patients with Del(5q) Cytogenetic Abnormalities – Results of the “AZALE” Trial

High Plasma Lysyloxidase Concentration Is Associated with Inferior Outcome and Extramedullary Disease in Patients with Acute Myeloid Leukemia

Characterization of Extramedullary Acute Myeloid Leukemia – Results of the AML96 Trial

The HCT-Specific Comorbidity Index Fails to Predict Survival After Allogeneic HCT In High Risk AML Patients - A Single Center Experience

PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia

Early Allogeneic Hematopoietic Cell Transplantation in Patients with High Risk AML - Final Results From the Randomized AML 2003 Trial

Sequential Combination of Azacitidine and Lenalidomide Can Target the TP53-Mutated Clone in Del(5q) Higher-Risk Myelodysplastic Syndromes

Acute Erythroleukemia Morphology Does Not Confer an Unfavourable Prognosis in Itself. Results of a Subgroup Analysis of the Prospective Randomized AML96-, AML2003 and AML60+ Studies of the Study Alliance Leukemia (SAL)

Aktive Filter

Suchergebnisse filtern